GLP1R and type 2 diabetes mellitus: The search strategy employed a combination of MeSH terms and free-text keywords, including “GLP-1 receptor agonists”, “semaglutide”, “exenatide”, “cardiovascular outcomes”, “major adverse cardiovascular events”, “type 2 diabetes”, and “atherosclerotic cardiovascular disease”.